Home
Products
Learn
About
Pricing
Log In
AVM
Asset Logo

Advance Metals Limited

πŸ‡¦πŸ‡Ί ASX

⛏️ MINING

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

+ 69.62%
Annual Growth

5 years average annual capital growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

4
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Advance Metals Ltd. engages in the business of investing in renewable energy and coal exploration. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-12-20. The firm is focused on identifying underexplored and undervalued projects with significant geological potential. The firm has 100% ownership of the Garnet Skarn Deposit, Augustus Project, the Anderson Creek Gold Project and the Yoquivo Silver Project. The Garnet Skarn Project is located in Adams County, Idaho (ID), United States. The project comprises about 2527 acres of unpatented mining claims. The project sits approximately 68 kilometers (km) northwest of the town of Council, accessible by highways and roads. The Augustus Project is a high-grade copper-gold advanced exploration and development project located in Yavapai County, Arizona, United States. The project totals about 902 hectares and resides approximately 125 km northwest of Phoenix, AZ. Its Yoquivo Silver Project is located in Chihuahua State, Mexico.

πŸ“ˆ Performance

Price History

+4.87%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.05

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in AVM

4

πŸ“Š Total Capital Earnings

$-503.643

πŸ”ƒ Average investment frequency

178 weeks

πŸ’΅ Average investment amount

$1,710

⏰ Last time a customer invested in AVM

10 days
AVM investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

20%

100k - 150k

20%

50k - 100k

Less than 50k

60%
πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

100%
πŸ™‹ Legal gender of investors

Female

Male

100%

Pearlers who invest in AVM also invest in...

Paradigm Biopharmaceuticals Limited.

PAR

Paradigm Biopharmaceuticals Ltd. is a biopharmaceutical company engaged in researching and developing therapeutic products for human use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-19. The firm is engaged in discovering, developing, and delivering pharmaceutical therapies. The company is focused on the development of injectable pentosan polysulfate sodium (iPPS/PPS) for the treatment of osteoarthritis (OA) and mucopolysaccharidosis (MPS). Pentosan polysulfate sodium is a semi-synthetic drug manufactured from the wood chips of European beech trees. Extracted glucurono-xylans are sulfated to produce a negatively charged product that mimics glycosaminoglycans (GAGs). The company develops PPS under the brand name Zilosul. PPS also inhibits the synthesis of the metalloproteinase, MMP-3 (Troeberg) involved in degrading cartilage. PPS also include treatment of joint function, mobility, and pain in patients with MPS; treating alphavirus-induced arthralgia (such as Ross River virus and Chikungunya); chronic heart failure (HF) and acute respiratory distress syndrome (ARDS).

πŸ™Œ Performance (5Yr p.a)

-17.54%

πŸ“Š Share price

$0.33 AUD

🧬 BIOTECHNOLOGY

Find Out More

πŸ“Š Share price

$0.09 AUD

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 7045.12m in AUM and 199 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

πŸ™Œ Performance (5Yr p.a)

10.22%

πŸ“Š Share price

$136.93 AUD

πŸ‡¦πŸ‡Ί AUSTRALIA

⛳️ DIVERSIFIED

πŸ’Έ FINANCIALS

πŸ“ˆ HIGH PRICE GROWTH

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

πŸ™Œ Performance (5Yr p.a)

19.19%

πŸ“Š Share price

$58.63 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ’° HIGH DIVIDEND

πŸ‡ΊπŸ‡Έ UNITED STATES

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

15.07%

πŸ“Š Share price

$133.72 AUD

🌏 GLOBAL

πŸ€– TECHNOLOGY

⛳️ DIVERSIFIED

πŸ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

πŸ™Œ Performance (5Yr p.a)

-2.44%

πŸ“Š Share price

$0.04 AUD

πŸ“Š Share price

$0.00 AUD
Compare
Add to watchlist